Blog Patient Care Sterile Compounds 
Omnicell
JANUARY 10, 2023
The latest revisions, which take effect November 1, 2023, exempt some robotic devices from surface sampling after every batch of Category 3 compounded sterile products (CSPs) and instead allow users of self-enclosed robotic devices to surface sample once per day. Subscribe today.
Omnicell
JANUARY 10, 2023
Implementing an intelligent infrastructure of automation and intelligence, supported by expert services to ensure optimization, is an opportunity for health systems to enhance medication distribution processes, support sterile compounding safety and efficiency, and ultimately improve pharmacy supply chain management. Subscribe today.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Omnicell
JANUARY 10, 2023
Stephanie Gallagher, PharmD, MBA Senior Clinical Product Marketing Manager, Omnicell The sterile compounding industry has been under great scrutiny due to alarming frequency and severity of adverse events from IV compounding, such as the New England Compounding Center catastrophe in 2012.
Omnicell
JANUARY 10, 2023
By connecting medication inventory across the entire healthcare infrastructure and leveraging the data pulled from that technology, there is a huge opportunity to reduce instances of human error, improve efficiency, control costs, ensure compliance and, ultimately, enhance patient care and safety.
Omnicell
JANUARY 10, 2023
Latest enhancements in the Summer Release are designed to improve medication management workflows and patient safety, allowing clinicians to provide greater patient care and reduce job-related stress and burnout. Improved Efficiency The U.S. healthcare system employs over 4.2 Learn more about these latest innovations here.
Expert insights. Personalized for you.
98 
Let's personalize your content